Cargando…

Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer

BACKGROUND: Immunotherapy is a novel hotspot for the treatment of pancreatic adenocarcinoma (PAAD). However, potential biomarkers which could identify the inflamed tumor microenvironment (TME) are urgently required. METHODS: In the present study, we measured the levels of B7-H3, B7-H4, and major tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Si, Shuping, Wang, Lei, Cao, Hui, Xu, Yuhua, Zhan, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881843/ https://www.ncbi.nlm.nih.gov/pubmed/35219310 http://dx.doi.org/10.1186/s12885-022-09294-w

Ejemplares similares

Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
por: Yang, Jiayue, et al.
Publicado: (2022)

The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer
por: Chen, Yan, et al.
Publicado: (2014)

B7‐H5/CD28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma
por: Chen, Qi, et al.
Publicado: (2019)

The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer [Retraction]
Publicado: (2022)

High expression of B7-H2 or B7-H3 is associated with poor prognosis in hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2019)

B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer
por: Mao, Yixiang, et al.
Publicado: (2014)

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
por: Inamura, Kentaro, et al.
Publicado: (2018)

Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes
por: Kim, Nah Ihm, et al.
Publicado: (2022)

Upregulation of the B7/CD28 family member B7-H3 in bladder cancer
por: WU, DEYAO, et al.
Publicado: (2015)

B7-H4 Expression Is Associated with Tumor Progression and Prognosis in Patients with Osteosarcoma
por: Dong, Qiang, et al.
Publicado: (2015)

Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
por: Qin, Xiaoyan, et al.
Publicado: (2021)

Soluble B7-H5 Is a Novel Diagnostic, Severity, and Prognosis Marker in Acute Pancreatitis
por: Xu, Ruoxin, et al.
Publicado: (2021)

B7-H5 costimulates human T cells via CD28H
por: Zhu, Yuwen, et al.
Publicado: (2013)

Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
por: Qin, Xiaoyan, et al.
Publicado: (2023)

Deficiency in B7-H1 (PD-L1)/PD-1 Coinhibition Triggers Pancreatic β-Cell Destruction by Insulin-Specific, Murine CD8 T-Cells
por: Rajasalu, Tarvo, et al.
Publicado: (2010)

B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021)

Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer
por: XU, MEI, et al.
Publicado: (2016)

B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8(+) tumor-infiltrating lymphocytes
por: You, Gihoon, et al.
Publicado: (2021)

Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis
por: Phares, Timothy W, et al.
Publicado: (2012)

B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer
por: Cui, YongHui, et al.
Publicado: (2016)

Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer
por: Li, Yixuan, et al.
Publicado: (2021)

B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8(+) T Lymphocytes In Vivo
por: Liu, Xingluo, et al.
Publicado: (2001)

B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating Bim
por: Gibbons, Rachel M., et al.
Publicado: (2012)

B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity
por: Zhou, Linlin, et al.
Publicado: (2019)

B7-H5 blockade enhances CD8(+) T-cell-mediated antitumor immunity in colorectal cancer
por: Wang, Jiayu, et al.
Publicado: (2021)

Clinical importance of B7-H3 expression in human pancreatic cancer
por: Yamato, I, et al.
Publicado: (2009)

B7-H3 overexpression in pancreatic cancer promotes tumor progression
por: ZHAO, XIN, et al.
Publicado: (2013)

7-p-Tolyl-10,11-dihydrobenzo[h]furo[3,4-b]quinolin-8(7H)-one
por: Shi, Chunling
Publicado: (2010)

7-(3-Nitrophenyl)-9,10-dihydro-7H-benzo[h]cyclopenta[b]quinolin-8(11H)-one
por: Li, Tuanjie, et al.
Publicado: (2011)

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
por: Borgmann, Mara, et al.
Publicado: (2022)

Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer
por: Zhang, Ting, et al.
Publicado: (2018)

Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density
por: Ulase, Dita, et al.
Publicado: (2021)

Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma
por: Chen, Weiwei, et al.
Publicado: (2013)

B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells
por: Li, Dongbao, et al.
Publicado: (2017)

Deficiency of N-linked glycosylation impairs immune function of B7-H6
por: Chen, Hanqing, et al.
Publicado: (2023)

Overexpression of B7H5/CD28H is associated with worse survival in human gastric cancer
por: Hu, Can, et al.
Publicado: (2019)

7-Bromo-4b-methyl-7,8-dihydro-4bH-9-thia-8a-azafluorene 9,9-dioxide
por: Gallucci, Judith C., et al.
Publicado: (2008)

Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients
por: Chen, Lujun, et al.
Publicado: (2016)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
por: Wang, Yuelong, et al.
Publicado: (2020)

Expression of CD24 and B7-H3 in breast cancer and the clinical significance
por: Cong, Fang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p5bbq088lkcfs14a7l054227hr